Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
Jordan · Delayed Price · Currency is JOD 3.120
-0.020 (-0.64%)
At close: Oct 28, 2026
ASE:HPIC Balance Sheet
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.54 | 9.56 | 9.05 | 7.25 | 6.63 | 7.73 |
Cash & Short-Term Investments | 8.54 | 9.56 | 9.05 | 7.25 | 6.63 | 7.73 |
Cash Growth | -5.33% | 5.70% | 24.76% | 9.39% | -14.23% | 31.91% |
Accounts Receivable | 10.61 | 11.74 | 10.65 | 9.67 | 9.34 | 7.44 |
Other Receivables | - | 0.08 | 0.09 | 0.05 | 0.05 | 0.02 |
Receivables | 10.61 | 11.82 | 10.75 | 9.71 | 9.39 | 7.46 |
Inventory | 3.8 | 2.61 | 3.55 | 3.59 | 3.61 | 3.24 |
Prepaid Expenses | 0.69 | 0.13 | 0.16 | 0.1 | 0.09 | 0.03 |
Other Current Assets | - | 0.4 | 0.3 | 0.58 | 0.43 | 0.54 |
Total Current Assets | 23.64 | 24.52 | 23.81 | 21.24 | 20.16 | 18.99 |
Property, Plant & Equipment | 13.33 | 12.68 | 13.49 | 12.93 | 13.68 | 14.04 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Deferred Charges | 0.22 | 0.22 | 0.19 | 0.24 | 0.18 | - |
Total Assets | 37.19 | 37.42 | 37.5 | 34.4 | 34.01 | 33.04 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.77 | 1.03 | 1.22 | 1.08 | 1.44 | 0.99 |
Accrued Expenses | 1.25 | 0.82 | 0.77 | 0.63 | 0.58 | 0.5 |
Short-Term Debt | 0.14 | 0.06 | 0.14 | 0.08 | 0.41 | 0.53 |
Current Portion of Long-Term Debt | 1.21 | 0.94 | 0.4 | 0.4 | 0.76 | 0.73 |
Current Income Taxes Payable | - | 0.34 | 0.33 | 0.36 | 0.46 | 0.5 |
Other Current Liabilities | - | 0.68 | 0.51 | 1.07 | 0.98 | 0.75 |
Total Current Liabilities | 4.36 | 3.88 | 3.36 | 3.62 | 4.62 | 4.01 |
Long-Term Debt | 2.51 | 2.48 | 3.29 | 1.46 | 0.03 | 0.82 |
Total Liabilities | 6.87 | 6.36 | 6.65 | 5.08 | 4.64 | 4.82 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 |
Retained Earnings | 20.82 | 21.56 | 21.34 | 19.82 | 19.87 | 18.72 |
Shareholders' Equity | 30.32 | 31.06 | 30.84 | 29.32 | 29.37 | 28.22 |
Total Liabilities & Equity | 37.19 | 37.42 | 37.5 | 34.4 | 34.01 | 33.04 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.86 | 3.48 | 3.83 | 1.94 | 1.19 | 2.08 |
Net Cash (Debt) | 4.68 | 6.08 | 5.22 | 5.31 | 5.44 | 5.65 |
Net Cash Growth | 3.82% | 16.50% | -1.76% | -2.28% | -3.69% | 53.13% |
Net Cash Per Share | 0.49 | 0.64 | 0.55 | 0.56 | 0.57 | 0.59 |
Filing Date Shares Outstanding | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 |
Total Common Shares Outstanding | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 | 9.5 |
Working Capital | 19.28 | 20.64 | 20.45 | 17.62 | 15.54 | 14.99 |
Book Value Per Share | 3.19 | 3.27 | 3.25 | 3.09 | 3.09 | 2.97 |
Tangible Book Value | 30.32 | 31.06 | 30.84 | 29.32 | 29.37 | 28.22 |
Tangible Book Value Per Share | 3.19 | 3.27 | 3.25 | 3.09 | 3.09 | 2.97 |
Land | - | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
Buildings | - | 6.81 | 6.8 | 6.58 | 6.56 | 6.23 |
Machinery | - | 12.34 | 11.99 | 10.52 | 10.31 | 9.76 |
Construction In Progress | 0.95 | 0.01 | 0.01 | 0.12 | 0.01 | 0.2 |